Arriving in the field of obesity management, retatrutide presents a distinct strategy. Unlike many current medications, retatrutide works as a dual agonist, simultaneously affecting both glucagon-like peptide-1 (GLP-1) https://fanniexjcj377178.theblogfairy.com/37586202/the-novel-retatrutide-the-glp-gip-binding-site-agonist